Get complete Patent Opposition Report for Arven Ilac Sanayi Ve Ticaret

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Arven Ilac Sanayi Ve Ticaret against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2400950Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)PhenolGLAXO GROUPFeb 14, 2020

Explore Arven Ilac Sanayi Ve Ticaret's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2682099Sep 2, 2020Dry Powder Inhaler Compositions Comprising Long Acting Muscorinic Antagonists3
EP2957552Jan 22, 2020Vilanterol Formulations3
EP2957551Jan 15, 2020Dry Powder Formulations Comprising Vilanterol4
EP3166641Sep 12, 2018A Process For The Preparation Of Formulations For Inhalation1